CTC Surveillance in Early-Stage Breast Cancer: What's Next?
OncLive,
Joseph A. Sparano, MD Blood-based biomarkers great potential for use in the management of breast and other cancers.
Joseph A. Sparano, MD Blood-based biomarkers great potential for use in the management of breast and other cancers.
« En amont de la chirurgie, certaines patientes atteintes de cancer du sein reçoivent une chimiothérapie néo-adjuvante et ce…